课题基金 / 基金详情

Development of a targeted drug delivery and high-throughput drug screening technology using droplet-based microfluidics and functionalized nano-structured materials

Development of a targeted drug delivery and high-throughput drug screening technology using droplet-based microfluidics and functionalized nano-structured materials
使用基于液滴的微流体和功能化纳米结构材料开发靶向药物输送和高通量药物筛选技术
批准号：
224477
负责人：
Zhang Xu
金额：
$9.83万
依托单位：
University of Waterloo (Ontario)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-02-01 至 2014-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=224477&lang=en
关键词：
Anticancer Drug Controlled Release Drug Delivery Drug Targeting Drug Toxicity Microfluidics Single Cell Study Synthesis Of Nanomaterials

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Personalized treatment approaches improve therapeutic safety and efficacy by tailoring therapies to the unique requirements of each patient's illness, physiology, and tolerability. The current project aims to develop a high-throughput drug screening platf
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金